EP1305440B1 - Isolation of microbial oils - Google Patents
Isolation of microbial oils Download PDFInfo
- Publication number
- EP1305440B1 EP1305440B1 EP01974095A EP01974095A EP1305440B1 EP 1305440 B1 EP1305440 B1 EP 1305440B1 EP 01974095 A EP01974095 A EP 01974095A EP 01974095 A EP01974095 A EP 01974095A EP 1305440 B1 EP1305440 B1 EP 1305440B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- oil
- cells
- process according
- cell
- microbial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000000813 microbial effect Effects 0.000 title claims abstract description 30
- 239000003921 oil Substances 0.000 title description 53
- 238000002955 isolation Methods 0.000 title description 4
- 210000004027 cell Anatomy 0.000 claims abstract description 56
- 238000000034 method Methods 0.000 claims abstract description 43
- 210000002421 cell wall Anatomy 0.000 claims abstract description 33
- 239000002904 solvent Substances 0.000 claims abstract description 29
- 108090000790 Enzymes Proteins 0.000 claims abstract description 14
- 102000004190 Enzymes Human genes 0.000 claims abstract description 14
- 238000005119 centrifugation Methods 0.000 claims abstract description 12
- 238000000265 homogenisation Methods 0.000 claims abstract description 10
- 230000000593 degrading effect Effects 0.000 claims abstract description 7
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims description 38
- 238000000926 separation method Methods 0.000 claims description 22
- 229940114079 arachidonic acid Drugs 0.000 claims description 19
- 235000021342 arachidonic acid Nutrition 0.000 claims description 19
- 238000010438 heat treatment Methods 0.000 claims description 11
- 241000907999 Mortierella alpina Species 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 239000004094 surface-active agent Substances 0.000 claims description 6
- 230000015572 biosynthetic process Effects 0.000 claims description 4
- 238000012258 culturing Methods 0.000 claims description 3
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 abstract description 38
- 238000000605 extraction Methods 0.000 abstract description 12
- 238000000855 fermentation Methods 0.000 abstract description 12
- 230000004151 fermentation Effects 0.000 abstract description 12
- 239000012071 phase Substances 0.000 abstract description 11
- 239000008346 aqueous phase Substances 0.000 abstract description 9
- 230000002255 enzymatic effect Effects 0.000 abstract description 5
- 239000000126 substance Substances 0.000 abstract description 4
- 238000009835 boiling Methods 0.000 abstract description 2
- 238000001035 drying Methods 0.000 abstract description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 15
- 150000002632 lipids Chemical class 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 244000005700 microbiome Species 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000002028 Biomass Substances 0.000 description 8
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- -1 fatty acid ester Chemical class 0.000 description 7
- 239000000411 inducer Substances 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 150000003904 phospholipids Chemical class 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 150000003626 triacylglycerols Chemical class 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 229930182558 Sterol Natural products 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 239000000306 component Substances 0.000 description 3
- 230000009089 cytolysis Effects 0.000 description 3
- 239000003599 detergent Substances 0.000 description 3
- 238000006911 enzymatic reaction Methods 0.000 description 3
- 235000021588 free fatty acids Nutrition 0.000 description 3
- 230000002934 lysing effect Effects 0.000 description 3
- 238000010297 mechanical methods and process Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 238000000053 physical method Methods 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 150000003432 sterols Chemical class 0.000 description 3
- 235000003702 sterols Nutrition 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 102000004882 Lipase Human genes 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- 102000003820 Lipoxygenases Human genes 0.000 description 2
- 108090000128 Lipoxygenases Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 238000004061 bleaching Methods 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000006037 cell lysis Effects 0.000 description 2
- 239000010779 crude oil Substances 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 235000019421 lipase Nutrition 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- 102000005575 Cellulases Human genes 0.000 description 1
- 108010084185 Cellulases Proteins 0.000 description 1
- 108010022172 Chitinases Proteins 0.000 description 1
- 102000012286 Chitinases Human genes 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- BDCFUHIWJODVNG-UHFFFAOYSA-N Desmosterol Natural products C1C=C2CC(O)C=CC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 BDCFUHIWJODVNG-UHFFFAOYSA-N 0.000 description 1
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108010059820 Polygalacturonase Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241001313871 Puma Species 0.000 description 1
- 241000382353 Pupa Species 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- AVSXSVCZWQODGV-DPAQBDIFSA-N desmosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@@H](CCC=C(C)C)C)[C@@]1(C)CC2 AVSXSVCZWQODGV-DPAQBDIFSA-N 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- 238000011143 downstream manufacturing Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 108010093305 exopolygalacturonase Proteins 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000013350 formula milk Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 108010002430 hemicellulase Proteins 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000009928 pasteurization Methods 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
- C12P7/6445—Glycerides
- C12P7/6463—Glycerides obtained from glyceride producing microorganisms, e.g. single cell oil
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B1/00—Production of fats or fatty oils from raw materials
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B1/00—Production of fats or fatty oils from raw materials
- C11B1/02—Pretreatment
- C11B1/025—Pretreatment by enzymes or microorganisms, living or dead
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B1/00—Production of fats or fatty oils from raw materials
- C11B1/06—Production of fats or fatty oils from raw materials by pressing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
- C12P7/6445—Glycerides
- C12P7/6472—Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
Definitions
- the present invention relates to the extraction (and then isolation) of a microbial (or single cell) oil comprising arachidonic acid (ARA), from single cell (or micro-) organisms which are Mortierella alpina cells.
- a microbial (or single cell) oil comprising arachidonic acid (ARA), from single cell (or micro-) organisms which are Mortierella alpina cells.
- ARA arachidonic acid
- the process of the invention involves the disruption or lysis of microbial cell walls, followed by separating the oil from the resulting cell debris.
- PUMAS Polyunsaturated fatty acids, or PUMAS, are found naturally and a wide variety of different PUFAs are produced by different single cell organisms (algae, fungi, etc). They have many uses, for example inclusion into foodstuffs (such as infant formula), nutritional supplements and pharmaceuticals.
- a microorganism In most microbial PUFA production processes a microorganism is first cultured in a fermenter in a suitable medium. The microbial biomass is then harvested and treated to enable subsequent extraction of a lipid from the biomass with a suitable solvent.
- the lipid is usually subjected to several refining steps. Care must be taken during the process because degradation can occur if the lipids are subjected to lipolysis or oxidising conditions, for example heating (in the presence of oxygen) and/or due to lipases or lipoxygenases.
- PUFAs can be extracted from whole intact cells using a solvent (see WO-A-97/36996 and WO-A-97/37032 ).
- solvents is a common way of removing lipids from microbial biomass ( WO-A-98/50574 ).
- GB-A-808128 describes a method of increasing the fatty contents of microorganisms which require i-inositol for normal growth, such as Saccharomyces .
- Extraction of the fat by means of an organic solvent (petroleum ether) is disclosed in the examples.
- An organic solvent petroleum ether
- a provisional specification mentions extraction with a solvent or by crushing and/or centrifuging.
- US-A-5338673 discloses a process for the selective production of polyunsaturated fatty acids from a culture of microalgae of Porphyrium cruentum.
- a process is described wherein a microalgal suspension is introduced into homogenizer-grinder resulting in burst of the microalgae.
- the microalgal fragments are separated from the buffered medium in a decanter or, alternatively, by centrifuging.
- the solid phase which is described to contain all the polyunsaturated fatty acids, is subjected to solvent extraction.
- WO-A-9704121 discloses a process in which a oil is extracted from oil containing microorganisms and contacting them in the presence of a water content of at least 70% by weight of that originally present in the cellular material with a water immiscible solvent for the oil, separating the solvent from the microorganisms and recovering the oil from the solvent.
- the separation of the solvent can be by centrifuging.
- Mortierella alpina is used as microorganism to produce oil comprising arachidonic acid (ARA).
- Graille et al, Oleagineux, Vol. 43, no 4 (1988) pages 181-190, XP008005863 relates to the extraction of oil, either from seeds or from pulp.
- the use of enzymes to assist the standard extraction process is mentioned.
- US-A-5897994 discloses a process wherein a mixture of fatty acids rich in polyunsaturated fatty acids is esterified by enzymatic catalysis and then the reaction mixture is saponified, which provides an organic phase containing esters and an aqueous phase which contains fatty acids, the phases are separated and the fatty acids of the aqueous phase are extracted by a non-polar solvent to obtain the fatty acids in the solvent. Separation between the aqueous phase and organic phase can be accentuated by addition of a saturated solution of sodium chloride.
- WO-A-0153512 which is a document under art.
- 54(3) EPC describes a method for extracting lipids from microorganisms without using a non-polar organic solvent. The process involves lysing the cells, and centrifuging the lysed cell mixture to obtain a heavy layer and a light layer and obtaining lipid from the light layer.
- the lipid can comprise a polyunsaturated fatty acid.
- lipids such as those comprising a PUFA, can be efficiently extracted from microbial cells without the need for solvent(s).
- Recent PUFA preparation processes advocate keeping the microbial cells intact ( WO-A-97/36996 ).
- This publication describes a PUFA production process where a microbial biomass is generated by fermenting a microorganism, and following fermentation the cells are heated. Water is removed from the biomass, and the resulting material extruded to form porous granules. The PUFA is then extracted from the intact cells inside the granules by contact with a solvent, usually hexane. The hexane is then evaporated to produce a crude oil. Throughout this process the cells are kept intact to prevent oxygen in the atmosphere contacting the PUFAs as it was thought that this would cause undesirable oxidation.
- a good quality PUFA oil can be achieved if the cells are in fact lysed: any potential oxidation by the atmosphere can be more than compensated by the advantage of avoiding the need for solvents.
- the ARA can be provided in the form of a free fatty acid, a salt, as a fatty acid ester (e.g. methyl or ethyl ester), as a phospholipid and/or in the form of a mono-, di-or triglyceride.
- a fatty acid ester e.g. methyl or ethyl ester
- the microbial cells can first be suitably cultured or fermented, such as in a fermenter vessel containing an (e.g. aqueous) culture medium.
- the fermentation conditions may be optimised for a high oil and/or PUFA content in the resulting biomass.
- the microorganisms may be killed and/or pasteurised. This may be to inactivate any undesirable enzymes, for example enzymes that might degrade the oil or reduce the yield of the PUFAs.
- the fermentation broth may then be removed (e.g. let out) from the fermenter, and may be passed to cell-wall disrupting equipment (e.g. a homogeniser). If necessary liquid (usually water) can (firstly) be removed therefrom. Any suitable solid liquid separation technique can be used. This (dewatering) may be by centrifugation and/or filtration.
- the cells may be washed, for example using an aqueous solution (such as water) for example to remove any extracellular water-soluble or water-dispersible compounds.
- the cells may then be ready for disruption or lysis.
- the cell walls of the microbial cells can then be disrupted (or lysed). This can be achieved using one or more enzymatic, physical or mechanical methods or techniques, for example at high shear conditions. Physical techniques include heating and/or drying the cells to a sufficient temperature whereby the cell walls are ruptured. This may comprise boiling.
- Enzymatic methods include lysis by one or more enzymes, e.g. cell wall degrading enzymes.
- the cell wall degrading enzyme may be a lytic enzyme.
- Other enzymes include (e.g. alkaline) proteases, cellulases, hemicellulases, chitinases and/or pectinases.
- Other cell wall degrading substances may be used instead of or in combination with one or more enzymes, e.g. salts, alkali, and/or one or more surfactants or detergents.
- a combination of physical, mechanical and/or enzymatic methods is also contemplated.
- a mechanical technique may comprise homogenisation, for example using a homogeniser.
- a homogeniser This may be a ball mill or any other machine able to disrupt the cell walls.
- Suitable homogenizers include high pressure homogenizers (for example at a pressure of 300 to 500kg/cm 2 or bar) such as a polytron homogenizer.
- Other homogenization techniques may involve mixing with particles, e.g. sand and/or glass beads (e.g. use of a bead mill).
- Alternative mechanical techniques include the use of milling apparatus, for example homoblenders.
- Other methods of disrupting the cell walls include ultrasound, spray drying and/or pressing or appliance of high pressure. This last technique is called cold-pressing: it may be performed at pressures of 100 to 600 or 700 bar (Atm or kg/cm 2 ), such as 150-500 bar, optimally from 200-400 bar.
- Homogenization is the preferred method of disrupting the cell walls.
- the pressure during disruption e.g. homogenisation
- the pressure during disruption may be from 300 to 900, such as 400 to 800, and optimally 500 to 600 or 700 bar (Atm or kg/m 2 ).
- Lower pressures may be employed if required, e.g. from 150 to 300 bar.
- working pressures can vary from 150 to 900 bar depending on the type of homogeniser, number of passes, etc.
- cell lysis can be performed chemically this is preferably not employed as (this stage in) the process is desireably solvent-free.
- the disruption of the cell walls may be performed either on the broth resulting from fermentation, for example the cells may still be contained in culture medium or such medium may be present.
- One or more additives my be added or present (such as an alkali metal salt, e.g. NaCl) during disruption or may be added after disruption (e.g. to a homogenised broth).
- an organic solvent e.g. MeOH, chloroform
- the disruption may be performed on the (optionally washed and/or concentrated) biomass (e.g following solid liquid separation). Disruption is therefore performed on an (e.g. aqueous) composition comprising the cells and water but not containing a solvent.
- disruption may be performed at a dry matter content of about 10 to 200g/l. This may be on the fermentation broth, for example after fermentation, or it may be derived from the broth, for example after the broth has been subjected to de-watering and/or solid/liquid separation.
- a separation inducer to encourage separation of the oil from the debris, may be added at this stage, such as to the homogenised material.
- the microbial oil is then separated from at least part of the cell wall debris formed.
- an oily or lipid phase or layer (and this may comprise the ARA).
- This may be a top or upper layer.
- This layer can be above a (lower) aqueous layer, e.g. containing cell wall debris.
- the oily layer (comprising the ARA) can then be separated from the aqueous layer ( or phase).
- One or more surfactants or detergents may be present or added to assist this process.
- the separation of the oil from at least some of the cell wall debris is preferably achieved or assisted by using a mechanical method, in particular by centrifugation.
- Suitable centrifuges can be obtained from Westfalia TM (semi- and industrial scale) or Beckman TM (e.g. laboratory centrifuges). Centrifugation (e.g. for a laboratory scale centrifuge) may last for from 2 or 4 to 8 or 15, such as from 3 or 5 to 7 or 12, optimally from 4 or 5 to 6 or 10 minutes (residence time).
- the centrifugal force (g) may be from 1,000 or 2,000 to 10,000 or 25,000, such as from 3,000 or 5,000 to 8,000 or 20,000, optimally from 4,000 to 6,000g, or from 7,000 to 9,000g, although centrifugation can be employed at g-forces up to 12,000g, 15,000g, 20,000g or 25,000g. Centrifugation may be at 4,000 to 14,000 rpm such as 6,000 to 12,000rpm, optimally at from 8,000 to 10,000rpm. One or more centrifugations may be necessary. The maximum g force may be lower if using certain centrifuges, for example this may be 6000g if using a Westfalia TM centrifuge (e.g. model NA-7).
- a Westfalia TM centrifuge e.g. model NA-7
- the flow rate may be from 100-500 litres/hour, such as 150 to 450 1/hr, optimally from 200 to 400 1/hr. Centrifugation may result in either a 2-phase system (a fatty or oily top layer and a lower aqueous layer) or a 3-phase system (a fatty or oily top layer, a middle aqueous layer and a bottom layer, usually containing the cell debris).
- a 2-phase system a fatty or oily top layer and a lower aqueous layer
- 3-phase system a fatty or oily top layer, a middle aqueous layer and a bottom layer, usually containing the cell debris.
- a separation inducer or agent that aids separation, may be added. This may be present or supplemented during (a), after (a) but before (b), or during (b). This may aid the formation of separate oil and aqueous phases.
- the inducer may increase the density of the aqueous phase, which may then become even more dense than the oily phase.
- Suitable inducers include alkali metal salts, e.g. NaCl.
- the inducer may be added at a concentration of 10-150g/l, such as 30-130 g/l, optimally from 50-100g/l.
- the oil may be free of any carotenoids, e.g. ⁇ -carotene.
- the process of the invention may further comprise extracting, purifying or isolating the oil or one more PUFAs.
- solvent excludes water, since the culture medium is usually aqueous and the cells may be washed with water).
- no (e.g. organic) solvent(s) may be employed either during disruption of the cell walls in (a), or in the separation of the PUPA from at least part of the cell wall debris, in (b).
- no (e.g. organic) solvent is used either in the extraction, purification or isolation of the oil or one or more PUFAs.
- the process can be solvent-free.
- stages (a), (b) and optionally also (c) can be performed without an (e.g.
- organic solvent for example without the need of a solvent for the oil (or PUFA), e.g. an alkane such as hexane, an alcohol (e.g. methanol) or a haloalkane (e.g. chloroform).
- a solvent for the oil e.g. an alkane such as hexane, an alcohol (e.g. methanol) or a haloalkane (e.g. chloroform).
- each or both of the disruption and separation stages (a) and (b) can also be performed without the need of a surfactant, for example in the absence of any detergents.
- a second aspect of the invention relates to an oil preparable (or prepared) by a process of the first aspect.
- the PUFA is preferably predominantly (such as greater than 50%, 70% or even 90% or 95%) in the form of triglycerides.
- the oil may have one or more of the following characteristics (or components):
- the PUFA (or oil containing a PUFA) may be subjected to further downstream processing, for example degumming, neutralisation, bleaching, deodorization, or winterization.
- a preferred process of the present invention therefore comprises:
- the heat treatment or pasteurization preferably inactivates or denatures one or more oil (or PUFA) degrading enzymes.
- the temperature of heating may be from 70 to 90°C, such as about 80°C. It may inactivate or denature enzymes such as lipases and/or lipoxygenases.
- one or more antioxidants for example vitamin C, ascorbyl palmitate and/or tocopherol
- heating may take place at an acid pH, for example to remove components such as phospholipids, trace metals, pigments, carbohydrates and/or proteins.
- the temperature may be from 50 to 80°C, such as 55 to 75°C, optimally from 60 to 70°C.
- the pH may be from 1 to 6, such as 2 to 5, optimally at a pH from 3 to 4. This can result in degumming and/or removal of proteins and/or water-soluble or water-dispersible compounds.
- a further heating step this time at alkaline pH, may employed.
- the pH may be from 8 to 13, such as from 9 to 12, optimally at a pH of from 10 to 11.
- the temperature may be the same as that described in the previous paragraph.
- a third aspect of the invention relates to apparatus for conducting the process of the first aspect.
- the third aspect may thus comprise:
- the cells and culture medium may be passed directly to the means in (b).
- Each of the means can be positioned in the order specified, so following the order of the stages of the process of the first aspect.
- Means for performing any or all of the disruption and separation steps as described earlier may be provided, for example means to add a separation inducer (e.g. to homogenised material), or for performing any of the steps described in the overall protocol (e.g. heating/pasteurising means, solid-liquid separation means, etc).
- Example 1 Preparation of crude PUFA (ARA) oil from a fermentation broth of Mortierella alpina.
- a fermentation broth of Mortierella alpina (previously pasteurized at 65°C for one hour) containing arachidonic acid (ARA) was homogenized once by means of an MC-4 APV Gaulin TM homogenizer at 600 bar (600 Atm) to disrupt the cell walls. NaCl was added to the homogenized broth to a final concentration of 100g/l. Subsequently the homogenized broth was centrifuged by means of a Sorval RC 5B centrifuge for 10 minutes at 9,000rpm (equivalent to about 20,000g) resulting in an arachidonic acid-enriched oily top layer and a lower aqueous layer containing the cell debris. Crude PUFA oil was recovered.
- the yield of oil was 9% (based on the oil in the cell).
- the (oil) layer had the following approximate composition: 0.1% desmosterols; 0.7% phospholipids; 6.7% triglycerides; 0.1 % diglycerides, 70% water and 20% medium components and cell debris.
- Example 2 Preparation of crude PLJFA (ARA) oil from a fermentation broth of Mortierella alpina.
- ARA PLJFA
- a fermentation broth of Mortierella alpina (previously pasteurized at 65°C for 1 hour) containing arachidonic acid (ARA) was homogenized once by means of an MC-4 APV Gaulin TM homogenizer at 600 bar (600 Atm) to disrupt the cell walls. Subsequently the homogenized broth was centrifuged by means of a Westfalia TM NA-7 disc centrifuge at maximum speed (about 8,000 rpm, equivalent to about 8,000g at the disc stack) resulting in an arachidonic acid-enriched oily top layer (that was recovered from the centrifuge) and a lower aqueous layer containing the cell debris.
- a crude PUFA oil was recovered: the yield of oil was 95% (based on the oil in the cell). The crude oil had the following approximate composition: 1 to 2% sterols and cell debris; 3 to 4% phospholipids; 4% monoglycerides; 6% diglycerides; and the remainder being triglycerides.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Fats And Perfumes (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Compounds Of Unknown Constitution (AREA)
Abstract
Description
- The present invention relates to the extraction (and then isolation) of a microbial (or single cell) oil comprising arachidonic acid (ARA), from single cell (or micro-) organisms which are Mortierella alpina cells. The process of the invention involves the disruption or lysis of microbial cell walls, followed by separating the oil from the resulting cell debris.
- Polyunsaturated fatty acids, or PUMAS, are found naturally and a wide variety of different PUFAs are produced by different single cell organisms (algae, fungi, etc). They have many uses, for example inclusion into foodstuffs (such as infant formula), nutritional supplements and pharmaceuticals.
- In most microbial PUFA production processes a microorganism is first cultured in a fermenter in a suitable medium. The microbial biomass is then harvested and treated to enable subsequent extraction of a lipid from the biomass with a suitable solvent. The lipid is usually subjected to several refining steps. Care must be taken during the process because degradation can occur if the lipids are subjected to lipolysis or oxidising conditions, for example heating (in the presence of oxygen) and/or due to lipases or lipoxygenases. The art teaches that to avoid oxidation (such as resulting from breaking open the cells and so exposing the contents to oxygen) PUFAs can be extracted from whole intact cells using a solvent (see
WO-A-97/36996 WO-A-97/37032 WO-A-98/50574 -
GB-A-808128 - Rema Vazhappilly et al., JOACS, Vol.75, no.3 (1998), pages 393-397, XP-002152068 describe the investigation of microalgal strains in photoautotrophic flask cultures for their potential for eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) production. The lipids are extracted by modified procedures of Bligh an Dyer, which involves homogenisation with chloroform/methanol/water, and separating the chloroform layer with the lipids.
-
US-A-5338673 discloses a process for the selective production of polyunsaturated fatty acids from a culture of microalgae of Porphyrium cruentum. A process is described wherein a microalgal suspension is introduced into homogenizer-grinder resulting in burst of the microalgae. The microalgal fragments are separated from the buffered medium in a decanter or, alternatively, by centrifuging. The solid phase, which is described to contain all the polyunsaturated fatty acids, is subjected to solvent extraction. -
WO-A-9704121 - Graille et al, Oleagineux, Vol. 43, no 4 (1988) pages 181-190, XP008005863 relates to the extraction of oil, either from seeds or from pulp. The use of enzymes to assist the standard extraction process is mentioned.
-
US-A-5897994 discloses a process wherein a mixture of fatty acids rich in polyunsaturated fatty acids is esterified by enzymatic catalysis and then the reaction mixture is saponified, which provides an organic phase containing esters and an aqueous phase which contains fatty acids, the phases are separated and the fatty acids of the aqueous phase are extracted by a non-polar solvent to obtain the fatty acids in the solvent. Separation between the aqueous phase and organic phase can be accentuated by addition of a saturated solution of sodium chloride. -
WO-A-0153512 - Although these extraction processes have been used for several years, the solvent needs to be removed and this results in extra cost. In addition, if the lipid is to be used in a foodstuff, it is important that certain solvents, such as hexane, are removed completely, or only remain in very small quantities. If the hexane is removed by evaporation then this may involve heating, and that not only adds to costs but can cause lipid degradation. Furthermore, with increasing environmental considerations, the use of solvents for the extraction of lipids is becoming increasingly expensive and unpopular.
- The present invention therefore seeks to solve or at least mitigate these problems. The applicant has found that lipids, such as those comprising a PUFA, can be efficiently extracted from microbial cells without the need for solvent(s).
- Therefore, according to the present invention there is provided a process for obtaining an oil from microbial cells which are Mortierella alpina cells, the oil comprising arachidonic acid (ARA), the process comprising:
- (a) disrupting the cell walls of the microbial cells to release the oil; and
- (b) separating, by centrifugation, the oil from at least part of the cell wall debris formed in (a); and
- Recent PUFA preparation processes advocate keeping the microbial cells intact (
WO-A-97/36996 - The ARA can be provided in the form of a free fatty acid, a salt, as a fatty acid ester (e.g. methyl or ethyl ester), as a phospholipid and/or in the form of a mono-, di-or triglyceride.
- In the process of the invention the microbial cells (or microorganisms) can first be suitably cultured or fermented, such as in a fermenter vessel containing an (e.g. aqueous) culture medium. The fermentation conditions may be optimised for a high oil and/or PUFA content in the resulting biomass. If desirable, and for example after fermentation is finished, the microorganisms may be killed and/or pasteurised. This may be to inactivate any undesirable enzymes, for example enzymes that might degrade the oil or reduce the yield of the PUFAs.
- The fermentation broth (biomass and culture medium) may then be removed (e.g. let out) from the fermenter, and may be passed to cell-wall disrupting equipment (e.g. a homogeniser). If necessary liquid (usually water) can (firstly) be removed therefrom. Any suitable solid liquid separation technique can be used. This (dewatering) may be by centrifugation and/or filtration. The cells may be washed, for example using an aqueous solution (such as water) for example to remove any extracellular water-soluble or water-dispersible compounds. The cells may then be ready for disruption or lysis.
- The cell walls of the microbial cells can then be disrupted (or lysed). This can be achieved using one or more enzymatic, physical or mechanical methods or techniques, for example at high shear conditions. Physical techniques include heating and/or drying the cells to a sufficient temperature whereby the cell walls are ruptured. This may comprise boiling.
- Enzymatic methods include lysis by one or more enzymes, e.g. cell wall degrading enzymes. The cell wall degrading enzyme may be a lytic enzyme. Other enzymes include (e.g. alkaline) proteases, cellulases, hemicellulases, chitinases and/or pectinases. Other cell wall degrading substances may be used instead of or in combination with one or more enzymes, e.g. salts, alkali, and/or one or more surfactants or detergents. A combination of physical, mechanical and/or enzymatic methods is also contemplated.
- If a mechanical technique is employed this may comprise homogenisation, for example using a homogeniser. This may be a ball mill or any other machine able to disrupt the cell walls. Suitable homogenizers include high pressure homogenizers (for example at a pressure of 300 to 500kg/cm2 or bar) such as a polytron homogenizer. Other homogenization techniques may involve mixing with particles, e.g. sand and/or glass beads (e.g. use of a bead mill). Alternative mechanical techniques include the use of milling apparatus, for example homoblenders. Other methods of disrupting the cell walls include ultrasound, spray drying and/or pressing or appliance of high pressure. This last technique is called cold-pressing: it may be performed at pressures of 100 to 600 or 700 bar (Atm or kg/cm2), such as 150-500 bar, optimally from 200-400 bar.
- Homogenization is the preferred method of disrupting the cell walls. There may be from 1 to 3 passes through the homogeniser, either at high and/or low during disruption (e.g. homogenisation) pressures. For example one may use a Gaulin™ homogenizer. The pressure during disruption (e.g. homogenisation) may be from 300 to 900, such as 400 to 800, and optimally 500 to 600 or 700 bar (Atm or kg/m2). Lower pressures may be employed if required, e.g. from 150 to 300 bar. Hence working pressures can vary from 150 to 900 bar depending on the type of homogeniser, number of passes, etc.
- Although cell lysis can be performed chemically this is preferably not employed as (this stage in) the process is desireably solvent-free.
- The disruption of the cell walls may be performed either on the broth resulting from fermentation, for example the cells may still be contained in culture medium or such medium may be present. One or more additives my be added or present (such as an alkali metal salt, e.g. NaCl) during disruption or may be added after disruption (e.g. to a homogenised broth). During disruption an organic solvent (e.g. MeOH, chloroform) is preferably not present. The disruption may be performed on the (optionally washed and/or concentrated) biomass (e.g following solid liquid separation). Disruption is therefore performed on an (e.g. aqueous) composition comprising the cells and water but not containing a solvent.
- In order to improve cell wall disruption, disruption may be performed at a dry matter content of about 10 to 200g/l. This may be on the fermentation broth, for example after fermentation, or it may be derived from the broth, for example after the broth has been subjected to de-watering and/or solid/liquid separation.
- If necessary a separation inducer, to encourage separation of the oil from the debris, may be added at this stage, such as to the homogenised material.
- The microbial oil is then separated from at least part of the cell wall debris formed. At this stage there may be in an oily or lipid phase or layer (and this may comprise the ARA). This may be a top or upper layer. This layer can be above a (lower) aqueous layer, e.g. containing cell wall debris. The oily layer (comprising the ARA) can then be separated from the aqueous layer ( or phase). One or more surfactants or detergents may be present or added to assist this process.
- The separation of the oil from at least some of the cell wall debris is preferably achieved or assisted by using a mechanical method, in particular by centrifugation. Suitable centrifuges can be obtained from Westfalia™ (semi- and industrial scale) or Beckman™ (e.g. laboratory centrifuges). Centrifugation (e.g. for a laboratory scale centrifuge) may last for from 2 or 4 to 8 or 15, such as from 3 or 5 to 7 or 12, optimally from 4 or 5 to 6 or 10 minutes (residence time).
- The centrifugal force (g) may be from 1,000 or 2,000 to 10,000 or 25,000, such as from 3,000 or 5,000 to 8,000 or 20,000, optimally from 4,000 to 6,000g, or from 7,000 to 9,000g, although centrifugation can be employed at g-forces up to 12,000g, 15,000g, 20,000g or 25,000g. Centrifugation may be at 4,000 to 14,000 rpm such as 6,000 to 12,000rpm, optimally at from 8,000 to 10,000rpm. One or more centrifugations may be necessary. The maximum g force may be lower if using certain centrifuges, for example this may be 6000g if using a Westfalia™ centrifuge (e.g. model NA-7). The flow rate may be from 100-500 litres/hour, such as 150 to 450 1/hr, optimally from 200 to 400 1/hr. Centrifugation may result in either a 2-phase system (a fatty or oily top layer and a lower aqueous layer) or a 3-phase system (a fatty or oily top layer, a middle aqueous layer and a bottom layer, usually containing the cell debris).
- A separation inducer, or agent that aids separation, may be added. This may be present or supplemented during (a), after (a) but before (b), or during (b). This may aid the formation of separate oil and aqueous phases. The inducer may increase the density of the aqueous phase, which may then become even more dense than the oily phase. Suitable inducers include alkali metal salts, e.g. NaCl. The inducer may be added at a concentration of 10-150g/l, such as 30-130 g/l, optimally from 50-100g/l.
- The oil may be free of any carotenoids, e.g. β-carotene. Following disruption and separation the process of the invention may further comprise extracting, purifying or isolating the oil or one more PUFAs.
- One advantage of the process of the invention is that one can avoid the need for a solvent. (In this context solvent excludes water, since the culture medium is usually aqueous and the cells may be washed with water). Thus, no (e.g. organic) solvent(s) may be employed either during disruption of the cell walls in (a), or in the separation of the PUPA from at least part of the cell wall debris, in (b). Preferably, no (e.g. organic) solvent is used either in the extraction, purification or isolation of the oil or one or more PUFAs. Thus, in essence, the process can be solvent-free. Thus stages (a), (b) and optionally also (c) can be performed without an (e.g. organic) solvent, for example without the need of a solvent for the oil (or PUFA), e.g. an alkane such as hexane, an alcohol (e.g. methanol) or a haloalkane (e.g. chloroform).
- Preferably, the use of a surfactant can also be avoided, and each or both of the disruption and separation stages (a) and (b) can also be performed without the need of a surfactant, for example in the absence of any detergents.
- A second aspect of the invention relates to an oil preparable (or prepared) by a process of the first aspect.
- If the oil comprises a PUFA, then the PUFA is preferably predominantly (such as greater than 50%, 70% or even 90% or 95%) in the form of triglycerides.
- The oil may have one or more of the following characteristics (or components):
- (a) sterols, e.g. desmosterol, or cell debris, such as from 0.01 to 1.0%, e.g. 0.05 to 0.5%, preferably from 0.1 to 0.2%;
- (b) phospholipids or triglycerides, such as from 0.1 to 2.0%, e.g. from 0.3 to 1.5%, preferably from 0.5 to 1.0%; and/or
- (c) diglycerides at no more than 0.1, 0.05 or 0.001%.
- The PUFA (or oil containing a PUFA) may be subjected to further downstream processing, for example degumming, neutralisation, bleaching, deodorization, or winterization.
- A preferred process of the present invention therefore comprises:
- (a) culturing microbial cells, for example under conditions whereby they produce a microbial oil or at least one PUFA;
- (b) optionally heating or pasteurising the cells, for example to kill the cells and/or to inactivate any undesirable enzymes;
- (c) optionally removing an (aqueous) liquid (such as dewatering), for example by centrifugation, filtration or a suitable solid-liquid separation technique;
- (d) optionally, washing the microbial cells, for example with water, preferably to remove extracellular water-soluble or water-dispersible compounds;
- (e) disrupting or lysing the cell walls of the microbial cells, for example by a physical, enzymatic or mechanical technique (such as homogenisation, e.g. with an homogeniser or a ball mill). This can release some of the oil and/or PUFA present in the microbial cells. The (mechanical) disruption may be supplemented with or substituted by chemical and/or enzymatic disruption. A separation inducer (for example to aid formation of two layers, in the next stage, may be added);
- (f) separation of the microbial oil (or PUFA) from the cell wall debris, for example formation and then separation of an oil phase from the resultant cell wall debris and/or aqueous phase. This may comprise centrifugation, optionally with the addition of one or more salts, a pH shift (towards alkaline), and may involve the presence of one or more cell degrading enzymes, surfactants or emulsifiers. One can obtain an (e.g. upper) oil phase and an (e.g. lower) aqueous phase. The oil phase may contain the PUFA. The aqueous phase may contain cell debris;
- (g) extraction, purification or isolation of the oil (or of the PUFA from the oil phase), for example resulting in a PUFA-containing oil; and
- (h) optionally acid treatment (or degumming), alkali treatment (or neutralisation), bleaching, deodorising, cooling (or winterisation). This may remove undesirable substances such as free fatty acids (FFAs), proteins, phospholipids, trace metals, pigments, carbohydrates, soaps, oxidation products, sulphur, pigment decomposition products, sterols, saturated triglycerides and/or mono- or di-glycerides.
- The heat treatment or pasteurization preferably inactivates or denatures one or more oil (or PUFA) degrading enzymes. The temperature of heating may be from 70 to 90°C, such as about 80°C. It may inactivate or denature enzymes such as lipases and/or lipoxygenases.
- One may add one or more (e.g. water and/or oil-soluble) antioxidants, for example vitamin C, ascorbyl palmitate and/or tocopherol, and this may be done after stage (b), or at a later stage for example after extraction, such as before or after any refining (step (h) above).
- There may be one or more additional heating steps, for example to remove other undesirable compounds or components. For example, heating may take place at an acid pH, for example to remove components such as phospholipids, trace metals, pigments, carbohydrates and/or proteins. Here the temperature may be from 50 to 80°C, such as 55 to 75°C, optimally from 60 to 70°C. The pH may be from 1 to 6, such as 2 to 5, optimally at a pH from 3 to 4. This can result in degumming and/or removal of proteins and/or water-soluble or water-dispersible compounds.
- Alternatively or in addition a further heating step, this time at alkaline pH, may employed. The pH may be from 8 to 13, such as from 9 to 12, optimally at a pH of from 10 to 11. The temperature may be the same as that described in the previous paragraph.
- A third aspect of the invention relates to apparatus for conducting the process of the first aspect. The third aspect may thus comprise:
- (a) means for culturing (or fermenting) microbial cells (e.g. a fermenter), optionally (e.g. directly) linked to;
- (b) means for disrupting (or lysing) cell walls of the microbial cells (e.g. a homogeniser), optionally linked to;
- (c) means for separating a (resulting) oil from (resulting) cell debris
- The cells and culture medium (e.g. broth) may be passed directly to the means in (b). Each of the means can be positioned in the order specified, so following the order of the stages of the process of the first aspect. Means for performing any or all of the disruption and separation steps as described earlier may be provided, for example means to add a separation inducer (e.g. to homogenised material), or for performing any of the steps described in the overall protocol (e.g. heating/pasteurising means, solid-liquid separation means, etc).
- Features or characteristics of one aspect of the invention are applicable to another aspect mutatis mutandis.
- The invention will now be described, by way of example, with reference to the following Examples which are provided by way of illustration only.
- A fermentation broth of Mortierella alpina (previously pasteurized at 65°C for one hour) containing arachidonic acid (ARA) was homogenized once by means of an MC-4 APV Gaulin™ homogenizer at 600 bar (600 Atm) to disrupt the cell walls. NaCl was added to the homogenized broth to a final concentration of 100g/l. Subsequently the homogenized broth was centrifuged by means of a Sorval RC 5B centrifuge for 10 minutes at 9,000rpm (equivalent to about 20,000g) resulting in an arachidonic acid-enriched oily top layer and a lower aqueous layer containing the cell debris. Crude PUFA oil was recovered.
- The yield of oil was 9% (based on the oil in the cell). The (oil) layer had the following approximate composition: 0.1% desmosterols; 0.7% phospholipids; 6.7% triglycerides; 0.1 % diglycerides, 70% water and 20% medium components and cell debris.
- A fermentation broth of Mortierella alpina (previously pasteurized at 65°C for 1 hour) containing arachidonic acid (ARA) was homogenized once by means of an MC-4 APV Gaulin™ homogenizer at 600 bar (600 Atm) to disrupt the cell walls. Subsequently the homogenized broth was centrifuged by means of a Westfalia™ NA-7 disc centrifuge at maximum speed (about 8,000 rpm, equivalent to about 8,000g at the disc stack) resulting in an arachidonic acid-enriched oily top layer (that was recovered from the centrifuge) and a lower aqueous layer containing the cell debris. A crude PUFA oil was recovered: the yield of oil was 95% (based on the oil in the cell). The crude oil had the following approximate composition: 1 to 2% sterols and cell debris; 3 to 4% phospholipids; 4% monoglycerides; 6% diglycerides; and the remainder being triglycerides.
Claims (9)
- A process for obtaining an oil from microbial cells which are Mortierella alpina cells, the oil comprising arachidonic acid (ARA), the process comprising:(a) disrupting the cell walls of the microbial cells to release the oil; and(b) separating, by centrifugation, the oil from at least part of the cell wall debris formed in (a); and
wherein no solvent for the oil is employed in stages (a) and (b). - A process according to claim 1, wherein the cells are physically, enzymatically or mechanically disrupted.
- A process according to claim 2, wherein the disrupting comprises homogenisation.
- A process according to claim 3, wherein the disrupting comprises homogenisation at a pressure of between 150 to 900 bar.
- A process according to any preceding claim which further comprises:(c) extracting, purifying or isolating the microbial oil, wherein no solvent for the oil is employed.
- A process according to any preceding claim wherein the separation results in the formation of an oily layer and an aqueous layer.
- A process according to claim 6, wherein the oily layer is an upper layer above the aqueous layer.
- A process according to any preceding claim which comprises, before (a), culturing or fermenting microbial cells under conditions that allow production of the oil, and if necessary pasteurising and/or heating the cells.
- A process according to any preceding claims wherein the disruption of the cell walls is assisted by one or more cell wall degrading enzymes or surfactants.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00306601A EP1178118A1 (en) | 2000-08-02 | 2000-08-02 | Isolation of microbial oils |
EP00306601 | 2000-08-02 | ||
PCT/EP2001/008903 WO2002010423A2 (en) | 2000-08-02 | 2001-08-01 | Isolation of microbial oils |
Publications (3)
Publication Number | Publication Date |
---|---|
EP1305440A2 EP1305440A2 (en) | 2003-05-02 |
EP1305440B1 true EP1305440B1 (en) | 2010-06-09 |
EP1305440B2 EP1305440B2 (en) | 2022-03-30 |
Family
ID=8173160
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00306601A Withdrawn EP1178118A1 (en) | 2000-08-02 | 2000-08-02 | Isolation of microbial oils |
EP01974095.0A Expired - Lifetime EP1305440B2 (en) | 2000-08-02 | 2001-08-01 | Isolation of microbial oils |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00306601A Withdrawn EP1178118A1 (en) | 2000-08-02 | 2000-08-02 | Isolation of microbial oils |
Country Status (19)
Country | Link |
---|---|
US (1) | US7431952B2 (en) |
EP (2) | EP1178118A1 (en) |
JP (4) | JP2004504849A (en) |
KR (6) | KR20030059086A (en) |
CN (1) | CN1282745C (en) |
AT (1) | ATE470719T1 (en) |
AU (2) | AU9371101A (en) |
BR (1) | BR0112942A (en) |
CA (2) | CA2417571C (en) |
DE (1) | DE60142339D1 (en) |
DK (1) | DK1305440T3 (en) |
EA (1) | EA006979B1 (en) |
ES (1) | ES2357614T3 (en) |
IL (2) | IL154146A0 (en) |
MX (1) | MXPA03000878A (en) |
NO (1) | NO20030510L (en) |
NZ (1) | NZ523884A (en) |
WO (1) | WO2002010423A2 (en) |
ZA (1) | ZA200300787B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9745538B2 (en) | 2013-12-20 | 2017-08-29 | MARA Renewables Corporation | Methods of recovering oil from microorganisms |
US10612065B2 (en) | 2015-05-29 | 2020-04-07 | Cargill, Incorporated | Heat treatment to produce glycosides |
Families Citing this family (107)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2336307C2 (en) | 2000-01-19 | 2008-10-20 | Мартек Биосайнсис Корпорейшн | Method of obtaining lipids (versions) and lipids obtained by this method |
ES2324640T3 (en) * | 2001-03-09 | 2009-08-12 | Societe Des Produits Nestle S.A. | OIL CONTAINING ONE OR SOME POLYIN-SATURATED ACID (S) OF LARGE CHAIN (S) RESULTING FROM A BIOMASS, PREPARATION PROCEDURE, FOOD, NUTRITIONAL, COSMETIC OR PHARMACEUTICAL COMPOSITION CONTAINING IT. |
EP2266525B1 (en) * | 2002-05-03 | 2012-07-11 | Martek Biosciences Corporation | High quality lipids and methods for producing by enzymatic liberation from biomass |
DE60325590D1 (en) | 2002-06-19 | 2009-02-12 | Dsm Ip Assets Bv | PASTEURIZATION PROCESS FOR MICROBIAL CELLS AND MICROBIAL OIL |
ES2312513T3 (en) * | 2002-09-04 | 2009-03-01 | Nestec S.A. | PROCEDURE FOR THE PREPARATION OF AN OIL CONTAINING ONE OR A FEW POLYINSATURATED LONG CHAIN FAT ACIDS COMING FROM BIOMASS, FOOD, NUTRITIONAL, COSMETIC OR PHARMACEUTICAL COMPOSITION CONTAINING SUCH OIL. |
US7601858B2 (en) * | 2004-08-17 | 2009-10-13 | Gs Cleantech Corporation | Method of processing ethanol byproducts and related subsystems |
WO2006046943A2 (en) * | 2004-10-22 | 2006-05-04 | Martek Biosciences Corporation | Methods for producing lipids by liberation from biomass |
DE102005003624A1 (en) * | 2005-01-26 | 2006-07-27 | Nutrinova Nutrition Specialties & Food Ingredients Gmbh | Antioxidative active extract, useful to prepare fatty acid composition, which is useful as e.g. an active agent in pharmaceutical composition, a food supplement and/or food ingredient or an animal feed, comprises Crypthecodinium species |
US9108140B2 (en) * | 2005-03-16 | 2015-08-18 | Gs Cleantech Corporation | Method and systems for washing ethanol production byproducts to improve oil recovery |
CA2611324C (en) | 2005-06-07 | 2017-02-14 | Ocean Nutrition Canada Limited | Eukaryotic microorganisms for producing lipids and antioxidants |
JP4819888B2 (en) * | 2005-07-01 | 2011-11-24 | マーテック バイオサイエンシーズ コーポレーション | Polyunsaturated fatty acid-containing oil products and their use and production |
WO2007063691A1 (en) * | 2005-11-29 | 2007-06-07 | Sanyo Chemical Industries, Ltd. | Bacteriolytic agent |
WO2008129358A2 (en) | 2006-08-01 | 2008-10-30 | Ocean Nutrition Canada Ltd. | Oil producing microbes and methods of modification thereof |
US7977076B2 (en) | 2006-12-29 | 2011-07-12 | Genifuel Corporation | Integrated processes and systems for production of biofuels using algae |
SG10201509864QA (en) | 2007-06-01 | 2015-12-30 | Solazyme Inc | Production of oil in microorganisms |
US8343753B2 (en) * | 2007-11-01 | 2013-01-01 | Wake Forest University School Of Medicine | Compositions, methods, and kits for polyunsaturated fatty acids from microalgae |
US8043496B1 (en) | 2008-03-18 | 2011-10-25 | Peter Allen Schuh | System for extracting oil from algae |
EP2145942A1 (en) * | 2008-07-15 | 2010-01-20 | Lonza Ltd. | Method for isolating oils from cells and biomasses |
PL2337857T3 (en) * | 2008-10-02 | 2017-09-29 | Gonzalez Ramon | Microalgae extract containing 3 -polyunsaturated fatty acids and method for extracting oil from micro-organisms |
EP2370554B1 (en) | 2008-11-28 | 2019-05-15 | Corbion Biotech, Inc. | Manufacturing of tailored oils in recombinant heterotrophic microorganisms |
US8207363B2 (en) * | 2009-03-19 | 2012-06-26 | Martek Biosciences Corporation | Thraustochytrids, fatty acid compositions, and methods of making and uses thereof |
CN101817738B (en) * | 2009-11-13 | 2013-08-14 | 厦门汇盛生物有限公司 | Method for extracting DHA from cells of algae and fungi by breaking cell walls |
BR112012017831B8 (en) | 2010-01-19 | 2021-05-25 | Dsm Ip Assets Bv | microbial oil, animal food and biomass comprising said microbial oil |
US8187861B1 (en) | 2010-01-26 | 2012-05-29 | Allen John Schuh | Phosphate removal-recovery and biofuel feedstock system |
CN101805670A (en) * | 2010-04-09 | 2010-08-18 | 上海中器环保科技有限公司 | Preparation method of microbial diesel |
AU2011257982B2 (en) | 2010-05-28 | 2017-05-25 | Corbion Biotech, Inc. | Tailored oils produced from recombinant heterotrophic microorganisms |
AR081558A1 (en) | 2010-06-01 | 2012-10-03 | Martek Biosciences Corp | EXTRACTION OF CELL LIPIDS AND PRODUCTS FROM THEM |
NL2004832C2 (en) * | 2010-06-07 | 2011-12-08 | Evodos B V | Separating biomass from an aqueous medium. |
US8906236B2 (en) | 2010-07-26 | 2014-12-09 | Sapphire Energy, Inc. | Process for the recovery of oleaginous compounds and nutrients from biomass |
BR112013002003A2 (en) | 2010-07-26 | 2019-09-24 | Sapphire Energy Inc | process for recovery of biomass oilseeds |
US9028696B2 (en) | 2010-07-26 | 2015-05-12 | Sapphire Energy, Inc. | Process for the recovery of oleaginous compounds from biomass |
EP2765180A1 (en) | 2010-09-21 | 2014-08-13 | Shell International Research Maatschappij B.V. | Process for separation of a mixture containing a microbial oil and a microbial substance |
US9085745B2 (en) * | 2010-10-18 | 2015-07-21 | Originoil, Inc. | Systems and methods for extracting non-polar lipids from an aqueous algae slurry and lipids produced therefrom |
SG10201509035WA (en) | 2010-11-03 | 2015-12-30 | Solazyme Inc | Microbial Oils With Lowered Pour Points, Dielectric Fluids Produced Therefrom, And Related Methods |
US20120329138A1 (en) | 2010-12-23 | 2012-12-27 | Shell Oil Company | Process for separation of a mixture containing a microbial substance and a liquid |
KR101964965B1 (en) | 2011-02-02 | 2019-04-03 | 테라비아 홀딩스 인코포레이티드 | Tailored oils produced from recombinant oleaginous microorganisms |
CA3026436A1 (en) * | 2011-02-11 | 2012-08-16 | E. I. Du Pont De Nemours And Company | Method for obtaining a lipid-containing composition from microbial biomass |
US20130045226A1 (en) * | 2011-02-11 | 2013-02-21 | E I Du Pont De Nemours And Company | Method for forming and extracting solid pellets comprising oil-containing microbes |
BR112013028621A2 (en) | 2011-05-06 | 2016-11-29 | Solazyme Inc | "Recombinant oilseed microalgae, method for producing microalgae biomass or a product produced from biomass, and method for producing a microalgae lipid composition". |
FR2975705B1 (en) | 2011-05-27 | 2014-12-26 | Roquette Freres | PROCESS FOR EXTRACTING SQUALENE FROM MICROALGUES |
AU2012285806B2 (en) | 2011-07-21 | 2017-09-14 | Dsm Ip Assets B.V. | Fatty acid compositions |
US8986977B2 (en) * | 2011-12-30 | 2015-03-24 | Alliance For Sustainable Energy, Llc | Disruption of cell walls for enhanced lipid recovery |
KR20200106088A (en) | 2012-01-16 | 2020-09-10 | 엘라자베스 맥켄나 | Compositions and methods for the treatment of hepatic diseases and disorders |
US20170232047A1 (en) * | 2012-01-16 | 2017-08-17 | Elizabeth McKenna | Control of Cellular Redox Levels |
AU2013247862B2 (en) | 2012-04-10 | 2016-02-04 | Kao Corporation | Method for producing fatty acid ester |
BR112014025719A8 (en) | 2012-04-18 | 2017-10-03 | Solazyme Inc | CUSTOMIZED OILS |
KR101432277B1 (en) * | 2012-05-22 | 2014-08-21 | 한국과학기술원 | Method for Extracting Lipid from Microalgae Using Cationoid Polymer and Method for Preparing Biodiesel Using the Extracted Lipid |
CN102702777B (en) * | 2012-06-07 | 2014-03-19 | 北京林业大学 | Method for extracting water-soluble carotenoid from plant materials through enzymatic hydrolysis |
US9487700B2 (en) * | 2012-09-11 | 2016-11-08 | Dic Corporation | Liquid crystal display device |
JP2015535829A (en) | 2012-09-21 | 2015-12-17 | マッケーナ、エリザベス | Naturally occurring CpG oligonucleotide compositions and therapeutic applications thereof |
JP2016506440A (en) * | 2012-12-19 | 2016-03-03 | バックマン・ラボラトリーズ・インターナショナル・インコーポレーテッドBuckman Laboratories International Incorporated | Bio-oil recovery method and system and separation aid therefor |
US10098371B2 (en) | 2013-01-28 | 2018-10-16 | Solazyme Roquette Nutritionals, LLC | Microalgal flour |
EP2762008A1 (en) * | 2013-02-05 | 2014-08-06 | Evonik Industries AG | Improving bioavailability of valuable materials from microorganisms by use of a rotor-stator system for cell disruption |
AU2014229307B2 (en) | 2013-03-13 | 2017-08-31 | Dsm Nutritional Products Ag | Engineering microorganisms |
KR102023756B1 (en) * | 2013-05-14 | 2019-09-23 | 에스케이이노베이션 주식회사 | Novel microalgae Thraustochytrium sp. LA6 (KCTC 12389BP), and producing method for bio-oil by using thereof |
CN104293475B (en) * | 2013-07-19 | 2017-07-25 | 中国石油化工股份有限公司 | A kind of method that grease is extracted from oleaginous microorganism |
FR3009619B1 (en) | 2013-08-07 | 2017-12-29 | Roquette Freres | BIOMASS COMPOSITIONS OF MICROALGUES RICH IN PROTEINS OF SENSORY QUALITY OPTIMIZED |
MX369685B (en) | 2013-10-04 | 2019-11-19 | Terravia Holdings Inc | Tailored oils. |
CN105814209B (en) | 2013-12-04 | 2022-02-25 | 日本水产株式会社 | Microbial oils containing dihomo-gamma-linolenic acid and microbial biomass containing dihomo-gamma-linolenic acid |
NZ721409A (en) * | 2013-12-20 | 2022-10-28 | Dsm Ip Assets Bv | Processes for obtaining microbial oil from microbial cells |
PL3082793T3 (en) * | 2013-12-20 | 2020-10-05 | Dsm Ip Assets B.V. | Processes for obtaining microbial oil from microbial cells |
KR20230119048A (en) * | 2013-12-20 | 2023-08-14 | 디에스엠 아이피 어셋츠 비.브이. | Process for extracting lipids for use in production of biofuels |
WO2015095693A2 (en) * | 2013-12-20 | 2015-06-25 | Dsm Ip Assets B.V. | Processes for obtaining microbial oil from microbial cells |
KR102426987B1 (en) * | 2013-12-20 | 2022-07-28 | 디에스엠 아이피 어셋츠 비.브이. | Processes for obtaining microbial oil from microbial cells |
JP6919827B2 (en) * | 2013-12-20 | 2021-08-18 | ディーエスエム ニュートリショナル プロダクツ アーゲーDSM Nutritional Products AG | How to recover oil from microorganisms |
EP3082792A4 (en) * | 2013-12-20 | 2017-08-16 | DSM IP Assets B.V. | Processes for obtaining microbial oil from microbial cells |
CN103789083B (en) * | 2014-02-17 | 2016-01-20 | 南京工业大学大丰海洋产业研究院 | A kind of fungal oil extracting method |
EP3620517A3 (en) | 2014-07-10 | 2020-07-29 | Corbion Biotech, Inc. | Ketoacyl acp synthase genes and uses thereof |
CN104356097B (en) * | 2014-10-20 | 2016-06-29 | 中国科学院广州能源研究所 | A kind of preparation method of microbial grease based epoxy |
CN104513704B (en) * | 2014-12-11 | 2018-01-12 | 湖北福星生物科技有限公司 | A kind of extracting method of no fishy smell DHA grease |
CN104479862A (en) * | 2014-12-31 | 2015-04-01 | 嘉必优生物工程(武汉)有限公司 | Method for extracting microbial oil |
AR104042A1 (en) | 2015-03-26 | 2017-06-21 | Mara Renewables Corp | HIGH-DENSITY PRODUCTION OF BIOMASS AND OIL USING GLUCEROL IN GROSS |
WO2016196368A1 (en) | 2015-05-29 | 2016-12-08 | Cargill, Incorporated | Fermentation methods for producing steviol glycosides with multi-phase feeding |
WO2016196321A1 (en) | 2015-05-29 | 2016-12-08 | Cargill, Incorporated | Fermentation methods for producing steviol glycosides using high ph and compositions obtained therefrom |
US9951326B2 (en) | 2015-07-13 | 2018-04-24 | MARA Renewables Corporation | Enhancing microbial metabolism of C5 organic carbon |
JP2018521680A (en) | 2015-08-06 | 2018-08-09 | カーギル・インコーポレイテッド | Fermentation method to produce steviol glycosides |
US10377792B2 (en) | 2016-03-16 | 2019-08-13 | The Texas A&M University System | Moisture displacement and simultaneous migration of surface-functionalized algae from water to an extraction solvent using ionic polyelectrolytes |
US10851395B2 (en) | 2016-06-10 | 2020-12-01 | MARA Renewables Corporation | Method of making lipids with improved cold flow properties |
US11419350B2 (en) | 2016-07-01 | 2022-08-23 | Corbion Biotech, Inc. | Feed ingredients comprising lysed microbial cells |
JP6998935B2 (en) | 2016-07-13 | 2022-01-18 | エボニック オペレーションズ ゲーエムベーハー | How to Separate Lipids from Dissolved Lipid-Containing Biomass |
CN110462014A (en) * | 2016-12-27 | 2019-11-15 | 赢创德固赛有限公司 | The method of lipid is separated from the biomass containing lipid |
WO2018122057A1 (en) * | 2016-12-27 | 2018-07-05 | Evonik Degussa Gmbh | Method of isolating lipids from a lipids containing biomass |
CN108570484A (en) * | 2017-03-07 | 2018-09-25 | 武汉普赛特膜技术循环利用有限公司 | A method of using fermentation method three times by purification enrichment DHA grease in algae zymotic fluid |
BR112020000421A2 (en) * | 2017-07-12 | 2020-09-01 | Bunge Global Innovation Llc | process of oil extraction from algae biomass |
CA3072451A1 (en) * | 2017-08-10 | 2019-02-14 | Dsm Ip Assets B.V. | Double centrifugation process for nutritive oil purification |
WO2019034354A1 (en) | 2017-08-17 | 2019-02-21 | Evonik Degussa Gmbh | Enhanced production of lipids by limitation of at least two limiting nutrient sources |
EP3668989A1 (en) | 2017-08-17 | 2020-06-24 | Evonik Operations GmbH | Enhanced production of lipids by limitation of at least two limiting nutrient sources |
EP3470502A1 (en) | 2017-10-13 | 2019-04-17 | Evonik Degussa GmbH | Method of separating lipids from a lysed lipids containing biomass |
CN107904016B (en) * | 2017-11-10 | 2021-04-20 | 海南华研胶原科技股份有限公司 | Red algae essential oil and preparation method thereof |
EP3527664A1 (en) | 2018-02-15 | 2019-08-21 | Evonik Degussa GmbH | Method of isolating lipids from a lipids containing biomass |
WO2019122030A1 (en) * | 2017-12-22 | 2019-06-27 | Dsm Ip Assets B.V. | Method of separating lipids from a lysed lipids containing biomass |
DE202018000893U1 (en) * | 2018-02-19 | 2019-05-22 | Dorothea Jürgens | Apparatus for environmentally and energy-saving ashing of corpses and body parts with prior separation of the liquid components and use of the combustible fraction for energetic reuse in and outside of the device |
EP3536800B1 (en) | 2018-03-09 | 2021-08-04 | TU München | Extraction of renewable triglycerides from oleaginous microorganisms |
CN112004919A (en) * | 2018-03-30 | 2020-11-27 | 帝斯曼知识产权资产管理有限公司 | Method for reducing emulsions by broth washing |
WO2019219396A1 (en) | 2018-05-15 | 2019-11-21 | Evonik Operations Gmbh | Method of isolating lipids from a lysed lipids containing biomass by emulsion inversion |
WO2019219443A1 (en) | 2018-05-15 | 2019-11-21 | Evonik Operations Gmbh | Method of isolating lipids from a lipids containing biomass with aid of hydrophobic silica |
CN108753457A (en) * | 2018-08-03 | 2018-11-06 | 梁云 | The method for improving microbial grease stability and safety |
CN108753458A (en) * | 2018-08-03 | 2018-11-06 | 梁云 | Improve the refinery practice of microbial grease stability and safety |
FR3085825B1 (en) | 2018-09-14 | 2021-07-16 | Fermentalg | MICROORGANISM OIL RICH IN DOCOSAHEXAENOIC ACID |
CN113574045A (en) * | 2019-03-14 | 2021-10-29 | 帝斯曼知识产权资产管理有限公司 | Method for obtaining lipids from microbial cell compositions |
CN111363614A (en) * | 2019-10-10 | 2020-07-03 | 润科生物工程(福建)有限公司 | Method for extracting arachidonic acid grease in non-solvent manner |
CN110760369A (en) * | 2019-11-08 | 2020-02-07 | 润科生物工程(福建)有限公司 | Method for purely physically extracting arachidonic acid oil |
CN111518611A (en) * | 2020-04-28 | 2020-08-11 | 上海容邦企业集团有限公司 | Sea-buckthorn fruit oil compound and preparation method thereof |
CN113684087B (en) * | 2020-05-18 | 2024-04-19 | 嘉必优生物技术(武汉)股份有限公司 | Solvent-free extraction method of microbial oil and obtained microbial oil |
EP3933016A1 (en) * | 2020-06-30 | 2022-01-05 | Evonik Operations GmbH | Method of isolating lipids from a lipids containing biomass |
FR3111912A1 (en) | 2020-06-24 | 2021-12-31 | Fermentalg | MICROORGANISM CULTURE PROCESS FOR LIPID ACCUMULATION |
KR20230115735A (en) * | 2022-01-27 | 2023-08-03 | 씨제이제일제당 (주) | Method for bio-oil extraction with improved oil recovery using cooling process |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5583019A (en) * | 1995-01-24 | 1996-12-10 | Omegatech Inc. | Method for production of arachidonic acid |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB808128A (en) * | 1955-12-01 | 1959-01-28 | Nat Res Dev | A method of increasing the fatty contents of such micro-organisms as yeasts, bacteria and moulds |
DE3248167A1 (en) | 1982-12-27 | 1984-06-28 | Wintershall Ag, 3100 Celle | TREHALOSELIPID TETRAESTER |
JPS61170397A (en) * | 1985-01-22 | 1986-08-01 | Agency Of Ind Science & Technol | Multi-stage extraction treatment of cell of mold belonging to mortierella genus |
JPS62278987A (en) * | 1986-05-26 | 1987-12-03 | Kanegafuchi Chem Ind Co Ltd | Recovery of enzymatic reaction product |
DK199887D0 (en) * | 1987-04-15 | 1987-04-15 | Danisco Bioteknologi As | yeast strain |
JPS63304990A (en) * | 1987-06-04 | 1988-12-13 | Meiji Seika Kaisha Ltd | Extraction of active ingredient in cell |
JPH0198494A (en) * | 1987-10-09 | 1989-04-17 | Agency Of Ind Science & Technol | Continuous reaction process with immobilized lipase |
KR900004067A (en) * | 1988-08-02 | 1990-03-27 | 김용원 | 100V / 220V connector, outlet and voltage selector plug |
US5130242A (en) | 1988-09-07 | 1992-07-14 | Phycotech, Inc. | Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids |
FR2656874B1 (en) | 1990-01-11 | 1992-04-03 | Commissariat Energie Atomique | PROCESS FOR THE PRODUCTION AND EXTRACTION OF ANTI-OXIDANTS FROM A CULTURE OF MICROORGANISMS AND PHOTOBIOREACTOR FOR THE IMPLEMENTATION OF THIS PROCESS. |
US5658767A (en) * | 1991-01-24 | 1997-08-19 | Martek Corporation | Arachidonic acid and methods for the production and use thereof |
FR2686619B1 (en) | 1992-01-28 | 1995-07-13 | Commissariat Energie Atomique | PROCESS FOR THE SELECTIVE PRODUCTION OF POLYUNSATURATED LIPIDS FROM A CULTURE OF PORPHYRIDIUM MICROALGAE AND TANK USED IN THIS PROCESS. |
DE4219360C2 (en) | 1992-06-12 | 1994-07-28 | Milupa Ag | Process for the production of lipids with a high proportion of long-chain, highly unsaturated fatty acids |
ATE181745T1 (en) | 1994-08-16 | 1999-07-15 | Frische Gmbh | METHOD FOR OBTAINING NON-WATER-SOLUBLE, NATIVE PRODUCTS FROM NATIVE MATERIAL MIXTURES USING CENTRIFUGAL FORCE |
KR100212644B1 (en) * | 1994-10-29 | 1999-08-02 | 토니헬샴 | Engine r.p.m. control apparatus and method for the construction machine using hydraulic pressure |
ATE178087T1 (en) * | 1995-05-04 | 1999-04-15 | Nestle Sa | METHOD FOR FRACTIONING FATTY ACIDS |
JPH099981A (en) * | 1995-06-28 | 1997-01-14 | Sekiyu Sangyo Kasseika Center | Separation of oil and water in microbial reaction of oily and aqueous two-phase system |
GB9514649D0 (en) * | 1995-07-18 | 1995-09-13 | Zeneca Ltd | Extraction of triglycerides from microorganisms |
EP2251410A3 (en) * | 1996-03-28 | 2011-09-28 | DSM IP Assets B.V. | Preparation of microbial polyunsaturated fatty acid containing oil from pasteurised biomass |
CN101928213B (en) * | 1996-03-28 | 2012-12-05 | Dsmip资产有限公司 | Process for the preparation of a granular microbial biomass and isolation of valuable compounds therefrom |
DK0935667T3 (en) | 1996-07-23 | 2007-04-10 | Nagase Chemtex Corp | Process for the preparation of docosahexaenoic acid and docosapentaenoic acid |
UA67742C2 (en) | 1997-05-02 | 2004-07-15 | Дсм Іп Ассетс Б.В. | A process for isolation of carotenoid crystals from microbial biomass |
JP3836231B2 (en) * | 1997-10-17 | 2006-10-25 | 日本化学飼料株式会社 | Highly unsaturated fatty acid-containing oil obtained from scallop midgut gland and method for producing the same |
WO1999032604A1 (en) | 1997-12-23 | 1999-07-01 | Dcv, Inc. Doing Business As Bio-Technical Resources | Linoleate isomerase |
JP2000041684A (en) * | 1998-07-29 | 2000-02-15 | Daicel Chem Ind Ltd | New d-amino acylase, its production and production of d-amino acid using the d-aminoacylase |
JP2000135096A (en) * | 1998-08-28 | 2000-05-16 | Tadayuki Imanaka | Surfactant, its production and use thereof |
RU2336307C2 (en) * | 2000-01-19 | 2008-10-20 | Мартек Биосайнсис Корпорейшн | Method of obtaining lipids (versions) and lipids obtained by this method |
US7730724B2 (en) * | 2007-05-10 | 2010-06-08 | Ford Global Technologies, Llc | Turbocharger shaft over-speed compensation |
-
2000
- 2000-08-02 EP EP00306601A patent/EP1178118A1/en not_active Withdrawn
-
2001
- 2001-08-01 JP JP2002516339A patent/JP2004504849A/en active Pending
- 2001-08-01 KR KR20037001502A patent/KR20030059086A/en active Search and Examination
- 2001-08-01 AT AT01974095T patent/ATE470719T1/en not_active IP Right Cessation
- 2001-08-01 WO PCT/EP2001/008903 patent/WO2002010423A2/en active Application Filing
- 2001-08-01 KR KR1020137023848A patent/KR101515317B1/en active IP Right Grant
- 2001-08-01 KR KR1020107002710A patent/KR20100019579A/en not_active Application Discontinuation
- 2001-08-01 IL IL15414601A patent/IL154146A0/en unknown
- 2001-08-01 CA CA2417571A patent/CA2417571C/en not_active Expired - Lifetime
- 2001-08-01 AU AU9371101A patent/AU9371101A/en active Pending
- 2001-08-01 CA CA2742152A patent/CA2742152C/en not_active Expired - Lifetime
- 2001-08-01 AU AU2001293711A patent/AU2001293711B2/en not_active Expired
- 2001-08-01 BR BR0112942-2A patent/BR0112942A/en not_active Application Discontinuation
- 2001-08-01 CN CNB018143016A patent/CN1282745C/en not_active Expired - Lifetime
- 2001-08-01 KR KR1020147015585A patent/KR101648277B1/en active IP Right Grant
- 2001-08-01 DK DK01974095.0T patent/DK1305440T3/en active
- 2001-08-01 EA EA200300212A patent/EA006979B1/en not_active IP Right Cessation
- 2001-08-01 KR KR1020127027187A patent/KR101447912B1/en active IP Right Grant
- 2001-08-01 KR KR1020117002571A patent/KR20110030661A/en active Search and Examination
- 2001-08-01 ES ES01974095T patent/ES2357614T3/en not_active Expired - Lifetime
- 2001-08-01 NZ NZ523884A patent/NZ523884A/en not_active IP Right Cessation
- 2001-08-01 US US10/343,861 patent/US7431952B2/en not_active Expired - Lifetime
- 2001-08-01 EP EP01974095.0A patent/EP1305440B2/en not_active Expired - Lifetime
- 2001-08-01 MX MXPA03000878A patent/MXPA03000878A/en active IP Right Grant
- 2001-08-01 DE DE60142339T patent/DE60142339D1/en not_active Expired - Lifetime
-
2003
- 2003-01-27 IL IL154146A patent/IL154146A/en active IP Right Grant
- 2003-01-29 ZA ZA200300787A patent/ZA200300787B/en unknown
- 2003-01-31 NO NO20030510A patent/NO20030510L/en not_active Application Discontinuation
-
2011
- 2011-09-08 JP JP2011196284A patent/JP2012019794A/en active Pending
-
2014
- 2014-02-21 JP JP2014031850A patent/JP2014138598A/en active Pending
-
2016
- 2016-05-06 JP JP2016093361A patent/JP2016208974A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5583019A (en) * | 1995-01-24 | 1996-12-10 | Omegatech Inc. | Method for production of arachidonic acid |
Non-Patent Citations (1)
Title |
---|
ATKINSON B.; MAVITUNA F.: "Biochemical Engineering and Biotechnology Handbook (edition 2)", 1991, MACMILLAN PUBLISHERS LTD * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9745538B2 (en) | 2013-12-20 | 2017-08-29 | MARA Renewables Corporation | Methods of recovering oil from microorganisms |
US9745539B2 (en) | 2013-12-20 | 2017-08-29 | MARA Renewables Corporation | Methods of recovering oil from microorganisms |
US10612065B2 (en) | 2015-05-29 | 2020-04-07 | Cargill, Incorporated | Heat treatment to produce glycosides |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1305440B1 (en) | Isolation of microbial oils | |
AU2001293711A1 (en) | Isolation of microbial oils | |
AU2014203384B2 (en) | Solventless extraction process | |
WO2006046943A2 (en) | Methods for producing lipids by liberation from biomass | |
AU2008229885B2 (en) | Solventless extraction process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20030220 |
|
AK | Designated contracting states |
Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: SCHAAP, ALBERT Inventor name: BIJL, HENDRIK, LOUIS |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: DSM IP ASSETS B.V. |
|
17Q | First examination report despatched |
Effective date: 20030710 |
|
17Q | First examination report despatched |
Effective date: 20040212 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REF | Corresponds to: |
Ref document number: 60142339 Country of ref document: DE Date of ref document: 20100722 Kind code of ref document: P |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: T3 |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: TRGR |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100609 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100609 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100910 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100609 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20101011 |
|
PLBI | Opposition filed |
Free format text: ORIGINAL CODE: 0009260 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20100831 |
|
PLAX | Notice of opposition and request to file observation + time limit sent |
Free format text: ORIGINAL CODE: EPIDOSNOBS2 |
|
26 | Opposition filed |
Opponent name: ROQUETTE FRERES, S.A. Effective date: 20110309 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2357614 Country of ref document: ES Kind code of ref document: T3 Effective date: 20110428 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R026 Ref document number: 60142339 Country of ref document: DE Effective date: 20110309 |
|
PLAF | Information modified related to communication of a notice of opposition and request to file observations + time limit |
Free format text: ORIGINAL CODE: EPIDOSCOBS2 |
|
PLBB | Reply of patent proprietor to notice(s) of opposition received |
Free format text: ORIGINAL CODE: EPIDOSNOBS3 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20100801 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100609 |
|
APBM | Appeal reference recorded |
Free format text: ORIGINAL CODE: EPIDOSNREFNO |
|
APBP | Date of receipt of notice of appeal recorded |
Free format text: ORIGINAL CODE: EPIDOSNNOA2O |
|
APBM | Appeal reference recorded |
Free format text: ORIGINAL CODE: EPIDOSNREFNO |
|
APBP | Date of receipt of notice of appeal recorded |
Free format text: ORIGINAL CODE: EPIDOSNNOA2O |
|
APAH | Appeal reference modified |
Free format text: ORIGINAL CODE: EPIDOSCREFNO |
|
APAW | Appeal reference deleted |
Free format text: ORIGINAL CODE: EPIDOSDREFNO |
|
APAY | Date of receipt of notice of appeal deleted |
Free format text: ORIGINAL CODE: EPIDOSDNOA2O |
|
APBM | Appeal reference recorded |
Free format text: ORIGINAL CODE: EPIDOSNREFNO |
|
APBP | Date of receipt of notice of appeal recorded |
Free format text: ORIGINAL CODE: EPIDOSNNOA2O |
|
APBQ | Date of receipt of statement of grounds of appeal recorded |
Free format text: ORIGINAL CODE: EPIDOSNNOA3O |
|
APBQ | Date of receipt of statement of grounds of appeal recorded |
Free format text: ORIGINAL CODE: EPIDOSNNOA3O |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 15 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 16 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 17 |
|
APAH | Appeal reference modified |
Free format text: ORIGINAL CODE: EPIDOSCREFNO |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 18 |
|
APBU | Appeal procedure closed |
Free format text: ORIGINAL CODE: EPIDOSNNOA9O |
|
PLAY | Examination report in opposition despatched + time limit |
Free format text: ORIGINAL CODE: EPIDOSNORE2 |
|
PLBC | Reply to examination report in opposition received |
Free format text: ORIGINAL CODE: EPIDOSNORE3 |
|
PLAY | Examination report in opposition despatched + time limit |
Free format text: ORIGINAL CODE: EPIDOSNORE2 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20200612 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20200715 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IE Payment date: 20200811 Year of fee payment: 20 Ref country code: ES Payment date: 20200901 Year of fee payment: 20 Ref country code: GB Payment date: 20200722 Year of fee payment: 20 Ref country code: DK Payment date: 20200811 Year of fee payment: 20 Ref country code: DE Payment date: 20200722 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20200811 Year of fee payment: 20 Ref country code: CH Payment date: 20200814 Year of fee payment: 20 Ref country code: IT Payment date: 20200713 Year of fee payment: 20 Ref country code: BE Payment date: 20200715 Year of fee payment: 20 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R071 Ref document number: 60142339 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: EUP Expiry date: 20210801 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MK Effective date: 20210731 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: PE20 Expiry date: 20210731 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MK9A |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MK Effective date: 20210801 |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: EUG |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20210801 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20211112 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20210731 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20210802 |
|
PUAH | Patent maintained in amended form |
Free format text: ORIGINAL CODE: 0009272 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: PATENT MAINTAINED AS AMENDED |
|
27A | Patent maintained in amended form |
Effective date: 20220330 |
|
AK | Designated contracting states |
Kind code of ref document: B2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R102 Ref document number: 60142339 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220330 |